Document Detail


Macrophage activation syndrome following Acinetobacter baumannii sepsis.
MedLine Citation:
PMID:  22285540     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Macrophage activation syndrome (MAS) is a systemic disorder with a high mortality, commonly associated with rheumatological conditions, but which can also occur as a complication of several infections. Here we present a case of MAS following Acinetobacter baumannii sepsis. Early institution of therapy with prednisolone, cyclosporine, colistin, and polymyxin resulted in a prompt clinical recovery. There are very few reported cases of Acinetobacter-related MAS that have been successfully treated.
Authors:
Teny Mathew John; Ceena N Jacob; Cherian C Ittycheria; Amrutha M George; Amith G Jacob; Saji Subramaniyam; Jabbar Puthiyaveettil; R Jayaprakash
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-27
Journal Detail:
Title:  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases     Volume:  -     ISSN:  1878-3511     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610933     Medline TA:  Int J Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Department of Internal Medicine, Government Medical College, Kottayam, Kerala, 686008, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Control of the potential health hazards of smoked fish by gamma irradiation.
Next Document:  Characterization of human phosphodiesterase 12 and identification of a novel 2'-5' oligoadenylate nu...